The BARD1/HP1 interaction: Another clue to heterochromatin involvement in homologous recombination

Por Fukuda, Takayo, Tsuruga, Tomoko, Kuroda, Takako, Takeuchi, Jun, Wu, Wenwen, Ohta, Tomohiko
Publicado no Mol Cell Oncol (2015)

Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, a...

Por Fukuda, Takayo, Tanabe, Masahiko, Kobayashi, Kokoro, Fukada, Ippei, Takahashi, Shunji, Iwase, Takuji, Ito, Yoshinori
Publicado no Springerplus (2015)

MED12 exon 2 mutations in phyllodes tumors of the breast

Por Nagasawa, Satoi, Maeda, Ichiro, Fukuda, Takayo, Wu, Wenwen, Hayami, Ryosuke, Kojima, Yasuyuki, Tsugawa, Ko-ichiro, Ohta, Tomohiko
Publicado no Cancer Med (2015)

Interaction of BARD1 and HP1 is required for BRCA1 retention at sites of DNA damage

Por Wu, Wenwen, Nishikawa, Hiroyuki, Fukuda, Takayo, Vittal, Vinayak, Asano, Masahide, Miyoshi, Yasuo, Klevit, Rachel E., Ohta, Tomohiko
Publicado no Cancer Res (2015)

Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype

Por Fukuda, Takayo, Horii, Rie, Gomi, Naoya, Miyagi, Yumi, Takahashi, Shunji, Ito, Yoshinori, Akiyama, Futoshi, Ohno, Shinji, Iwase, Takuji
Publicado no Springerplus (2016)

Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage

Por Fukuda, Takayo, Wu, Wenwen, Okada, Maiko, Maeda, Ichiro, Kojima, Yasuyuki, Hayami, Ryosuke, Miyoshi, Yasuo, Tsugawa, Ko-ichiro, Ohta, Tomohiko
Publicado no Cancer Sci (2015)